STOCK TITAN

BioLife Solutions to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

BioLife Solutions (NASDAQ: BLFS) will announce its third quarter 2020 financial results post-market on November 5, 2020. The Company will host a conference call at 4:30 p.m. ET to discuss its financial overview and business updates. Investors can access the call via the company's Investor Relations page. BioLife is a key supplier of bioproduction products for cell and gene therapies, offering solutions like CryoStor® and HypoThermosol® to aid in the preservation and management of biological products.

Positive
  • Upcoming third quarter 2020 financial results announcement.
  • Hosting a conference call to provide insights into financial results and business updates.
Negative
  • None.

BOTHELL, Wash., Oct. 29, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that the Company's third quarter 2020 financial results will be released after market close on Thursday, November 5th, 2020, and that the Company will host a conference call and live webcast at 4:30 p.m. ET (1:30 p.m. PT) that afternoon. Management will provide an overview of the Company's financial results and a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at http://www.biolifesolutions.com/earnings. Alternatively, you may access the live conference call by dialing 1 (844) 825-0512 with the following Conference ID: 1296883. A webcast replay will be available approximately two hours after the call and will be archived on http://www.biolifesolutions.com/ for 90 days.

About BioLife Solutions

BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Our products and services portfolio includes our proprietary CryoStor® freeze media, HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, and Custom Biogenic Systems high capacity storage freezers. For more information, please visit www.biolifesolutions.com, and follow BioLife on Twitter.

Media & Investor Relations
Roderick de Greef
Chief Financial and Chief Operating Officer
(425) 686-6002
rdegreef@biolifesolutions.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biolife-solutions-to-report-third-quarter-2020-financial-results-and-provide-business-update-on-november-5-2020-301163333.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions report its Q3 2020 financial results?

BioLife Solutions will report its Q3 2020 financial results on November 5, 2020.

What time is the conference call for BioLife Solutions Q3 earnings?

The conference call for BioLife Solutions Q3 earnings will be at 4:30 p.m. ET on November 5, 2020.

How can I access the BioLife Solutions Q3 2020 financial results webcast?

You can access the BioLife Solutions Q3 2020 financial results webcast through their Investor Relations page at www.biolifesolutions.com/earnings.

What products does BioLife Solutions specialize in?

BioLife Solutions specializes in bioproduction products and services for cell and gene therapies, including CryoStor® and HypoThermosol®.

BioLife Solutions Inc.

NASDAQ:BLFS

BLFS Rankings

BLFS Latest News

BLFS Stock Data

937.99M
46.39M
2.01%
101.14%
7.76%
Medical Instruments & Supplies
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
BOTHELL